Delivery Order SPE2DB22D3016-SPE2DB24FASL9
Award Date
4/12/24
Potential Completion Date
4/15/24
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The firm fixed price contract is for the supply of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, with a potential value of $2,596.53 and a completion date of February 28, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp holds an Indefinite...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $95,139.62, is for the supply of VEMLIDY 25 MG TABLET, a pharmaceutical product, with a completion date of February 28, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a leading pharmaceutical sourcing and distribution company. The contract is for the delivery of VEMLIDY 25 MG TABLET in 30 count units, with a total ceiling value of $1,109.14 and a performance period through March 26, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, serves as the prime contractor on this award, which is not set aside for any...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,057.22, is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product. The contract has a firm fixed price and is designated as a delivery order, with an ultimate completion date of March 25, 2025. This contract is not associated with a set-aside program. AmerisourceBergen...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $19,615.61 award is for the supply of VEMLIDY 25 MG TABLET UU 30S, a prescription pharmaceutical product, with a completion date of March 19, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical and medical supplies to U.S. government...
This federal contract award is a delivery order valued at $2,845.52 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and a period of performance through April 12, 2024. AmerisourceBergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $2,744.10 firm fixed price contract is for the supply of the pharmaceutical product VEMLIDY 25 MG TABLET in 30-tablet units. The order has an ultimate completion date of August 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA to procure a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,206,161 units of the pharmaceutical product VEMLIDY 25 MG TABLET in 30-count packages. The $5,193.06 delivery order has a performance period through April 9, 2024. This award is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with a potential value of up to $999,999,999.00...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VEMLIDY 25 MG TABLET UU 30S. The contract has a total ceiling value of $8,062.55 and a period of performance through March 19, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $23,111.68 firm fixed-price contract is for the supply of VEMLIDY 25 MG TABLET, a prescription medication, with an ultimate completion date of August 28, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, to...